Teva Pharmaceuticals USA Recall: Leucovorin Calcium for Injection, USP 350 mg/vial, 17.5 m
Teva Pharmaceuticals USA Recall: Leucovorin Calcium for Injection, USP 350 mg/vial, 17.5 m is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Teva Pharmaceuticals USA; Product: Leucovorin Calcium for Injection, USP 350 mg/vial, 17.5 mL single-use vials, Rx only, Teva Parenteral Medicines,
| Recalling firm | Teva Pharmaceuticals USA |
|---|---|
| Product | Leucovorin Calcium for Injection, USP 350 mg/vial, 17.5 mL single-use vials, Rx only, Teva Parenteral Medicines, Inc. Irvine, CA 92618, NDC 0703-5145-01 |
| Reason for recall | Lack of Assurance of Sterility |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Product was distributed Nationwide, including Puerto Rico. |
| Recall initiated | 20210729 |
| Recall number | D-0737-2021 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →